Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute coronary syndrome
MedTech
FDA approves heart monitor unanimously rejected by expert panel
FDA approved the device after Angel carried out additional clinical analysis of a troubled trial that got short shrift from its expert panel in 2016.
Nick Paul Taylor
Apr 20, 2018 8:55am
UCL-developed stem therapy culled from Pfizer's pipeline
Aug 1, 2017 9:31am
Creavo raises $17M to ready heart attack test for market
Jul 5, 2017 10:00am